All Drugs and Chemicals

Vaccines

Heptavalent Pneumococcal Conjugate Vaccine

Immunologic Factors

Immunization Schedule patients \<7 years.

Immunization Schedule patients \> or = to 7 years and \<11 years of age

Immunization Schedule patients \> or = to 11 years of age

* Time 0 months: Prevnar 13 #1, Hib #1
* Time 1 months: Pediarix #1
* Time 2 months: Prevnar 13 #2, Hib #2
* Time 3-4 months: Pediarix #2
* Time 4-6 months: Draw post vaccine titers
* Time 6-12 months: Administer Hepatitis #3 to patients not immunized prior to treatment for cancer, or with negative Hepatitis B titers after two immunizations.

Immunization Schedule patients <7 years.

* Time 0 months: Hib #1, Prevnar 13 #1, Hepatitis B #1
* Time 1 month: Td#1, IPV #1(inactivated polio virus vaccine), Hepatitis B #2
* Time 2-3 months: Prevnar 13 #2, Hib #2
* Time 3-6 months: Td #2, Draw post vaccine titers Time 6-12 months: Administer Hepatitis #3 to patients not immunized prior to treatment for cancer, or with negative Hepatitis B titers after two immunizations.

Immunization Schedule patients > or = to 7 years and <11 years of age

* Time 0 month: Hib#1, Prevnar 13#1, Hepatitis B #1
* Time 1 month: Tdap(BOOSTRIX), Hepatitis B #2
* Time 2-3 months: Hib #2, Prevnar 13#2, Menactra
* Time 3-6 months: IPV, Draw post vaccine titers
* Time 6-12 months: Gardasil (dose #2 given 2 months after first dose, and dose #3 given 6 months after first dose)

Immunization Schedule patients > or = to 11 years of age

Nancy Kernan, MD

This study will look at your body's response to the new immunizations. We want to see how well they will protect you. Immunization is the same as vaccination. Our goal is to protect you as much as we can. We do not want you to have the measles, mumps, or whooping cough. We are doing the study because there is no standard way to re-immunize people after cancer treatments.

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Phase II Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Memorial Sloan Kettering Cancer Center

Fibrinolytic Agents

Anticoagulants

Heparin

Calcium heparin

This study will require the collection of a finger-puncture capillary blood specimen in addition to one green stoppered heparin containing collection tube. This is taken pre-therapy. The capillary whole blood specimen will be used to perform a creatinine determination on the "investigational" hand-held creatinine analyzer using special test strips for the analysis.

hand-held POC creatinine analyzer-blood test

Martin Fleisher, PhD

This study is being done to see if the Nova Creatinine Meter can give a correct measure of creatinine (a blood test used to measure kidney function) when the blood is taken from a capillary (smallest type of blood vessels). The Nova Creatinine Meter is a hand held device that can be used in a clinic to measure creatinine in about 50 seconds. Current laboratory creatinine testing can take up to an hour. Since chemotherapy patients need to have their creatinine measured prior to treatment, this meter could make testing easier and faster.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Prospective Trial of Vaccine Responses in Childhood Cancer Survivors	NCT00505063	Childhood Cance... Multiple Diseas...	Immunization Sc... Immunization Sc... Immunization Sc...	2 Years - 18 Years	Memorial Sloan Kettering Cancer Center
Prospective Trial of Vaccine Responses in Childhood Cancer Survivors	NCT00505063	Childhood Cance... Multiple Diseas...	Immunization Sc... Immunization Sc... Immunization Sc...	2 Years - 18 Years	Memorial Sloan Kettering Cancer Center
Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device	NCT00607529	Cancer	hand-held POC c...	18 Years -	Memorial Sloan Kettering Cancer Center
Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device	NCT00607529	Cancer	hand-held POC c...	18 Years -	Memorial Sloan Kettering Cancer Center

Spots Global Cancer Trial Database for multiple diseases